Exclusively dedicated to uniting AD, QC, and CMC leaders the 3rd Oligonucleotide CMC & Analytical Development Summit is the only industry-led meeting solving your impurity, regulatory, and cost-efficiency challenges in this rapidly evolving field.

Across the three days, you'll get the chance to hear from KOLs like Ionis Pharmaceuticals, AstraZeneca, and CAMP4 Therapeutics as the present their data-driven case studies on managing quality, regulatory affairs, and cost-efficient manufacturing.

Deep dive into the major challenges of streamlining analytical tools, process development, and look towards greener chemistries to ensure global uptake of oligonucleotide drugs.

This isn't just an event, it's an investment in the future of your teams technical capabilities. Bringing together siRNA, mRNA, ASO, oligo and oligo-conjugate developers, this definitive summit fosters comprehensive development, ensuring the resilience and longevity of this rapidly advancing modality.